Align TechnologyALGNEarnings & Financial Report
Align Technology, Inc. is an American manufacturer of 3D digital scanners and Invisalign clear aligners used in orthodontics and restorative workflow. It was founded in 1997 and is headquartered in Tempe, Arizona. The company manufactures the aligners in Juarez, Mexico, and its scanners in Israel and China. The company is best known for its Invisalign system, which is a clear aligner treatment used to straighten teeth.
ALGN Q3 2025 Key Financial Metrics
营收
$995.7M
毛利润
$639.2M
营业利润
$96.3M
净利润
$56.8M
毛利率
64.2%
营业利润率
9.7%
净利率
5.7%
同比增长
1.8%
EPS
$0.78
资金流向
Align Technology Q3 2025 Financial Summary
Align Technology reported revenue of $995.7M for Q3 2025, with a net profit of $56.8M (5.7% margin). Cost of goods sold was $356.5M, operating expenses totaled $542.9M.
Key Financial Metrics
| Total Revenue | $995.7M |
|---|---|
| Net Profit | $56.8M |
| Gross Margin | 64.2% |
| Operating Margin | 9.7% |
| Report Period | Q3 2025 |
Align Technology Annual Revenue by Year
Align Technology annual revenue history includes year-by-year totals (for example, 2024 revenue was $4.0B).
| Year | Annual Revenue |
|---|---|
| 2024 | $4.0B |
| 2023 | $3.9B |
| 2022 | $3.7B |
利润表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $956.7M | $997.4M | $1.03B | $977.9M | $995.2M | $979.3M | $1.01B | $995.7M |
| 同比增长 | 6.1% | 5.8% | 2.6% | 1.8% | 4.0% | -1.8% | -1.6% | 1.8% |
资产负债表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $6.08B | $6.16B | $6.16B | $6.37B | $6.21B | $6.10B | $6.22B | $6.23B |
| 总负债 | $2.45B | $2.40B | $2.40B | $2.42B | $2.36B | $2.31B | $2.31B | $2.28B |
| 股东权益 | $3.63B | $3.76B | $3.76B | $3.94B | $3.85B | $3.79B | $3.91B | $3.96B |
现金流量表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $46.9M | $28.7M | $159.8M | $263.7M | $286.1M | $52.7M | $128.7M | $188.7M |
Other Health Care Companies
WST
West Pharmaceutical Services
营收
$805.0M
净利润
$132.1M
ABT
Abbott Laboratories
营收
$11.4B
净利润
$1.6B
ABBV
AbbVie
营收
$15.8B
净利润
$186.0M
A
Agilent Technologies
营收
$1.9B
净利润
$434.0M
AMGN
Amgen
营收
$9.9B
净利润
$1.3B
BAX
Baxter International
营收
$3.0B
净利润
$-1.1B
BDX
Becton Dickinson
营收
$5.3B
净利润
$382.0M
TECH
Bio-Techne
营收
$295.9M
净利润
$38.0M
BIIB
Biogen
营收
$2.3B
净利润
$-48.9M
BSX
Boston Scientific
营收
$5.3B
净利润
$670.0M